Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Endocyte

  • Companion Diagnostics: Improving Development Success and Patient...
    ... Harnessing Imaging Technologies Holds Additional Promise Pharma companies such as Endocyte, GlaxoSmithKline, and Pfizer are currently utilizing companion imaging diagnostics to ...
    8-5-2013
  • Molecular Imaging Driving Development
    ... is instead conjugated to a 99mTc-based imaging group. [Endocyte] Christopher P. Leamon, Ph.D., vp, research at Endocyte, presented a novel and personalized approach to identify ...
    8-1-2013
  • Exploiting Folate Pathways to Treat Cancer
    Endocyte Uses an Imaging Agent to Select Patients Likely to Respond to Its Therapies Endocyte is developing targeted small molecule drug conjugates, each with a companion imaging ...
    4-1-2013
  • People in the News
    ... David Tran joined PAC as vp of product management and marketing...Endocyte named Lesley Russell to its board of directors...Particle Sciences hired Deepak Tiwari, Ph.D. , as ...
    2-1-2013
  • Endocyte Supports Oncology Studies with Medidata Clinical Cloud
    Endocyte has selected the Medidata Solutions cloud-based platform to support the execution ... Ma, director of clinical operations at Endocyte. "This will ensure that we obtain the ...
    12-14-2012
  • People in the News
    Kozin was North American president of L.E.K. Consulting. He also serves on the boards of Endocyte, Medical Simulation, UFP Technologies, CrunchTime! Information Systems, and ...
    11-15-2012
  • People in the News
    ... Gordon has more than 14 years of operational and leadership experience. Previously she was senior director, project delivery at PRA International. Endocyte named Marc Kozin to its ...
    9-1-2012
  • Merck & Co. Pays Endocyte $120M for Phase III Folate Receptor...
    Merck & Co. is paying Endocyte $120 million up front for worldwide rights to develop and ... Endocyte could receive up to another $880 million in milestone payments dependent on ...
    4-16-2012
  • What Does It Take to Swing the IPO Window Open for Biotechs?
    ... Among big winners so far in 2011 is Endocyte, a developer of small molecule drug conjugates and companion diagnostics for cancer and inflammatory diseases. Shares of Endocyte ...
    6-16-2011
  • Biotech Posts Strong Third-Quarter Results
    ... Endocyte ( www.endocyte.com ) is developing targeted therapies for the treatment of cancer and other serious diseases. Pacific Biosciences ( www.pacificbiosciences.com ) has ...
    11-1-2010
  • Late-Stage Cancer Vaccines Set to Launch
    ... Another company that has active products in clinical development for cancer is privately held Endocyte (www.endocyte.com). It has a receptor-based technology that targets tumor ...
    3-1-2007

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll